Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -5.86% vs 6.82% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 2,50,600.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -7.98% vs 20.59% in Mar 2024
Compare Balance Sheet Results of Par Drugs & Che.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.30
8.88
3.42
38.51%
Share Warrants & Outstandings
Total Reserve
86.67
197.20
-110.53
-56.05%
Shareholder's Funds
98.97
206.08
-107.11
-51.97%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.58
0.90
2.68
297.78%
Other Long Term Liabilities
0.00
0.16
-0.16
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.27
1.55
-1.28
-82.58%
Total Non-Current Liabilities
3.85
2.60
1.25
48.08%
Current Liabilities
Trade Payables
10.89
65.08
-54.19
-83.27%
Other Current Liabilities
1.10
12.30
-11.20
-91.06%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
4.58
1.60
2.98
186.25%
Total Current Liabilities
16.57
78.98
-62.41
-79.02%
Total Liabilities
119.39
287.67
-168.28
-58.50%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
75.09
97.19
-22.10
-22.74%
Less: Accumulated Depreciation
36.18
60.27
-24.09
-39.97%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
38.91
36.92
1.99
5.39%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
8.10
-8.10
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
25.07
5.08
19.99
393.50%
Long Term Loans & Advances
0.00
1.48
-1.48
-100.00%
Other Non Current Assets
0.54
0.00
0.54
0.00%
Total Non-Current Assets
64.53
51.58
12.95
25.11%
Current Assets Loans & Advances
Current Investments
0.00
25.12
-25.12
-100.00%
Inventories
6.11
129.54
-123.43
-95.28%
Sundry Debtors
16.71
49.04
-32.33
-65.93%
Cash and Bank
27.58
25.51
2.07
8.11%
Other Current Assets
4.28
3.95
0.33
8.35%
Short Term Loans and Advances
0.19
2.93
-2.74
-93.52%
Total Current Assets
54.86
236.09
-181.23
-76.76%
Net Current Assets (Including Current Investments)
38.29
157.11
-118.82
-75.63%
Total Current Assets Excluding Current Investments
54.86
210.97
-156.11
-74.00%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
119.39
287.67
-168.28
-58.50%
Contingent Liabilities
0.10
1.53
-1.43
-93.46%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
80.44
232.03
-151.59
-65.33%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 38.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.86% vs 6.82% in Mar 2024
Annual - Investments
Investments 25.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2,50,600.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 54.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.98% vs 20.59% in Mar 2024






